Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

MLA

Patrizio Mattei, et al. “Discovery of Carmegliptin: A Potent and Long-Acting Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.” Bioorganic & Medicinal Chemistry Letters, vol. 20, Feb. 2010, pp. 1109–13. EBSCOhost, https://doi.org/10.1016/j.bmcl.2009.12.024.

APA

Patrizio Mattei, Joerg Huwyler, Patrick Di Giorgio, Buelent Kocer, Robert Narquizian, Etienne Rauber, Bernd Michael Loeffler, Alexander Macdonald, Michael Hennig, Elena Sebokova, Markus Boehringer, Holger Fischer, Bernd Kuhn, & Urs Sprecher. (2010). Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters, 20, 1109–1113. https://doi.org/10.1016/j.bmcl.2009.12.024

Chicago

Patrizio Mattei, Joerg Huwyler, Patrick Di Giorgio, Buelent Kocer, Robert Narquizian, Etienne Rauber, Bernd Michael Loeffler, et al. 2010. “Discovery of Carmegliptin: A Potent and Long-Acting Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.” Bioorganic & Medicinal Chemistry Letters 20 (February): 1109–13. doi:10.1016/j.bmcl.2009.12.024.